Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?What's the recommended schedule for lurbinectedin side effect checks?Pramlintide approval date?Is januvia still on the market?When is the expected fda decision date for apotex's ruxolitinib resubmission?
See the DrugPatentWatch profile for Tremfya
Do you mean the US launch date, another country, or a different Tremfya indication (psoriatic arthritis, etc.)? Launch timelines vary by region and indication. For context: - Tremfya (guselkumab) was FDA-approved in July 2017 for adults with moderate-to-severe plaque psoriasis. - The US launch followed soon after that approval in late 2017. If you tell me the country and the indication you’re interested in, I can give a precise launch date.
Other Questions About Tremfya :